Literature DB >> 19151622

Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions.

Jian-Qiang Lu1, Yan Fan, Alim P Mitha, Robert Bell, Luanne Metz, G R Wayne Moore, V Wee Yong.   

Abstract

Multiple sclerosis (MS) has neurodegenerative features including neuronal and axonal loss and widespread atrophy of the brain and spinal cord. The cause of this neurodegeneration has been largely attributed to inflammation, but other mechanisms, including those associated with classic neurodegenerative diseases such as the alpha-synucleinopathies, might also be involved in MS pathogenesis. In this study, 96 brain lesions containing varying degrees of inflammatory activity from 12 autopsied MS cases were compared with corresponding regions from 6 neuropathologically normal controls; 2 cerebral biopsy lesions from an MS patient were also studied. We found alpha-synuclein immunoreactivity in the cytoplasm of cells in MS lesions with inflammatory activity but not in control samples. alpha-Synuclein-immunoreactive cells were identified in active (15/15 lesions in the brainstem, 9/13 in cerebral hemispheres) and chronic active (14/15 in the brainstem, 12/22 in cerebral hemispheres) lesions but were absent in chronic inactive lesions (0/31); the greater immunoreactivity in brainstem compared with cerebral hemisphere lesions was significant (p < 0.05). Double-immunofluorescence staining revealed localization of alpha-synuclein immunoreactivity mostly in neurons, microglia/macrophages, and oligodendrocytes, and only rarely in astrocytes. The results suggest that alpha-synuclein expression regulated by inflammatory signals may contribute to neurodegenerative processes in MS lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151622     DOI: 10.1097/NEN.0b013e318196e905

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  14 in total

1.  Dynamic transport and localization of alpha-synuclein in primary hippocampal neurons.

Authors:  Mong-Lin Yang; Linda Hasadsri; Wendy S Woods; Julia M George
Journal:  Mol Neurodegener       Date:  2010-02-09       Impact factor: 14.195

Review 2.  Parkinson's disease: what the model systems have taught us so far.

Authors:  Swagata Ghatak; Dorit Trudler; Nima Dolatabadi; Rajesh Ambasudhan
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 3.  Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.

Authors:  Amit Bar-Or; Peter Rieckmann; Anthony Traboulsee; V Wee Yong
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

4.  α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells.

Authors:  Neda Saffarian Tousi; Daniel J Buck; J Thomas Curtis; Randall L Davis
Journal:  Neurosci Lett       Date:  2011-12-13       Impact factor: 3.046

5.  Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Authors:  Koichi Wakabayashi; Yasuo Miki; Kunikazu Tanji; Fumiaki Mori
Journal:  Cerebellum       Date:  2022-04-26       Impact factor: 3.847

6.  Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.

Authors:  Christine L Kragh; Amanda M Gysbers; Edward Rockenstein; Karen Murphy; Glenda M Halliday; Eliezer Masliah; Poul Henning Jensen
Journal:  Neurobiol Dis       Date:  2013-12-17       Impact factor: 5.996

7.  Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.

Authors:  Vicente Lieberknecht; Stella C Junqueira; Mauricio P Cunha; Thaís A Barbosa; Luiz F de Souza; Igor S Coelho; Adair R S Santos; Ana Lúcia S Rodrigues; Alcir L Dafré; Rafael C Dutra
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 8.  Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.

Authors:  Vanesa Sanchez-Guajardo; Christopher J Barnum; Malú G Tansey; Marina Romero-Ramos
Journal:  ASN Neuro       Date:  2013-04-30       Impact factor: 4.146

9.  Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.

Authors:  Yohannes Haile; Katia Carmine-Simmen; Camille Olechowski; Bradley Kerr; R Chris Bleackley; Fabrizio Giuliani
Journal:  J Neuroinflammation       Date:  2015-09-04       Impact factor: 8.322

10.  α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.

Authors:  Benjamin Ettle; Kristina Kuhbandner; Stefanie Jörg; Alana Hoffmann; Jürgen Winkler; Ralf A Linker
Journal:  J Neuroinflammation       Date:  2016-08-26       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.